Results 101 to 110 of about 3,877 (197)

Immunohistochemical analysis for thrombospondin type-1 domain-containing 7A (THSD7A) and M-type phospholipase A2 receptor (PLA2R).

open access: yes, 2015
Immunostaining for THSD7A (a, c, e) and PLA2R (b, d, f) in patients with idiopathic membranous nephropathy (a–d) and secondary membranous nephropathy (e, f). Original magnification: ×400.
Hideo Yasuda (710367)   +4 more
core   +1 more source

Predictors of evolution to stage ≥4 CKD in patients with PLA2R-related PMN.

open access: yes, 2017
Predictors of evolution to stage ≥4 CKD in patients with PLA2R-related PMN.
Isabelle Brocheriou (3812980)   +6 more
core   +1 more source

PLA2R and membranous nephropathy: A 3 year prospective Australian study

open access: yes, 2016
PLA2R and membranous nephropathy: A 3 year prospective Australian ...
PA Hill (14541284)   +2 more
core  

The intensity of PLA2R and C4d immunoexpression in primary membranous nephropathy

open access: yes, 2019
Objective: Antibodies against the phospholipase A2 receptor (PLA2R) on podocyte membranes result in the formation of immune complexes that cause loss of function of theglomerular basement membrane in primary membranous nephropathy (PMN).
FİLİNTE, DENİZ   +10 more
core   +2 more sources

PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy [PDF]

open access: yes
The phospholipase A2 receptor antibody (PLA2R-Ab) test is a valuable first-line diagnostic tool for primary membranous nephropathy (MN), helping to identify PLA2R-related MN and potentially eliminating the need for a kidney biopsy in some individuals. By
King, N.   +8 more
core   +1 more source

Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases

open access: yes, 2017
Autoantibody against phospholipase A2 receptor (anti-PLA2R) is a sensitive and specific biomarker of idiopathic membranous nephropathy (iMN), being found in approximately 70% of iMN patients and only occasionally in other glomerular diseases.
Ravera, F.   +59 more
core   +1 more source

The prevalence of anti-PLA2R Abs evaluated by ELISA and CIIFA in MN patients.

open access: yes, 2016
The prevalence of anti-PLA2R Abs evaluated by ELISA and CIIFA in MN patients.
Tomohiro Saito (659385)   +9 more
core   +1 more source

Serum and urine anti-PLA2R antibody correlation with albuminuria in idiopathic membranous nephropathy

open access: yesFrontiers in Immunology
ObjectiveThis study aimed to investigate the correlation between anti-phospholipase A2 receptor (PLA2R) levels in serum and urine with clinical parameters, particularly albuminuria, in patients with idiopathic membranous nephropathy (IMN).MethodsWe ...
Xiaogang Liu   +4 more
doaj   +1 more source

Anticorps anti-EPN et anti-PLA2R dans les glomérulopathies extramembraneuses: Le point en 2014

open access: yes, 2015
Membranous nephropathy (MN) is the most common cause for nephrotic syndrome in adults and occurs as an idiopathic (primary) or secondary disease. Since the early 2000's, substantial advances have been made in the understanding of the molecular bases of ...
Broeders, Emine Nilufer   +8 more
core  

ROC analysis of serum anti-PLA2R antibodies between the remission and non-remission groups at initial diagnosis.

open access: yes
(A) ROC curve of serum anti-PLA2R-IgG and anti-PLA2R-IgG4 between the remission and non-remission groups. (B)ROC curve of serum eGFR+ anti-CTLD678 IgG4+ urinary protein between the remission and non-remission groups.
Yuan Qin (260617)   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy